Join to View Full Profile
C4 Therapeutics, Inc490 Arsenal Way, Suite 100East Watertown, MA 02472
Dr. Crystal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Medical oncologist (MD-PhD), board certified; Industry experience in early phase oncology drug development including small molecules, IO and CAR-T; Translational research: acquired resistance to targeted therapy in lung cancer.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2013
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2006 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2025
Publications & Presentations
PubMed
- 18 citationsA Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, With or Without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Ca...Komal Jhaveri, Dejan Juric, Yoon Sim Yap, Sara Cresta, Rachel M. Layman
Clinical Cancer Research. 2021-11-01 - 668 citationsProspects for combining targeted and conventional cancer therapy with immunotherapyPhilip Gotwals, Scott Cameron, Daniela Cipolletta, Viviana Cremasco, Adam S. Crystal
Nature Reviews. Cancer. 2017-05-01 - 225 citationsA Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients With Advanced Solid Tumors and LymphomasJeffrey R. Infante, P. A. Cassier, John F. Gerecitano, Petronella O. Witteveen, Rashmi Chugh
Clinical Cancer Research. 2016-12-01
Press Mentions
Tango Therapeutics Presents Preclinical Data on Precision Oncology Programs at the American Association of Cancer Research 2023 Annual MeetingApril 18th, 2023- Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business HighlightsMarch 27th, 2023
- AACR: C4's Multiple Myeloma Data Prompts Dosing Switch, Giving Patients a Longer Treatment ReprieveApril 8th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
